Glen Wunderlich

4.0k total citations · 2 hit papers
41 papers, 2.9k citations indexed

About

Glen Wunderlich is a scholar working on Psychiatry and Mental health, Clinical Psychology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Glen Wunderlich has authored 41 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Psychiatry and Mental health, 11 papers in Clinical Psychology and 10 papers in Cellular and Molecular Neuroscience. Recurrent topics in Glen Wunderlich's work include Sexual function and dysfunction studies (10 papers), Sexuality, Behavior, and Technology (6 papers) and Amino Acid Enzymes and Metabolism (5 papers). Glen Wunderlich is often cited by papers focused on Sexual function and dysfunction studies (10 papers), Sexuality, Behavior, and Technology (6 papers) and Amino Acid Enzymes and Metabolism (5 papers). Glen Wunderlich collaborates with scholars based in Canada, United States and Germany. Glen Wunderlich's co-authors include Mark Stacy, Valerie Voon, Daniel Weintraub, Jacqueline Whetteckey, Anthony E. Lang, Andrew Siderowf, Marc N. Potenza, Anita H. Clayton, Diane J. Lewis-D’Agostino and Leonard R. Derogatis and has published in prestigious journals such as Annals of Neurology, Brain Research and Psychopharmacology.

In The Last Decade

Glen Wunderlich

40 papers receiving 2.9k citations

Hit Papers

Impulse Control Disorders in Parkinson Disease 2007 2026 2013 2019 2010 2007 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Impulse Control Disorders in Parkinson Disease
    2010 971 citations Daniel Weintraub, Juergen Koester et al. Archives of Neurology profile →
  2. Validation of the Female Sexual Distress Scale-Revised for Assessing Distress in Women with Hypoactive Sexual Desire Disorder
    2007 560 citations Anita H. Clayton, Diane J. Lewis-D’Agostino et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Glen Wunderlich Canada 22 1.2k 1.1k 919 555 440 41 2.9k
Marı́a J. Portella Spain 39 389 0.3× 1.4k 1.3× 848 0.9× 406 0.7× 923 2.1× 115 3.9k
Raphael M. Bonelli Austria 24 869 0.7× 372 0.4× 359 0.4× 962 1.7× 341 0.8× 65 2.5k
Seishi Terada Japan 31 900 0.8× 742 0.7× 253 0.3× 263 0.5× 271 0.6× 107 2.6k
José Alvir United States 20 232 0.2× 1.6k 1.5× 372 0.4× 460 0.8× 689 1.6× 36 2.8k
Tillmann H. C. Krüger Germany 30 319 0.3× 978 0.9× 1.2k 1.4× 170 0.3× 345 0.8× 140 2.9k
Ronald A. Remick Canada 32 287 0.2× 1.3k 1.2× 598 0.7× 377 0.7× 355 0.8× 103 3.4k
Claudio Lucetti Italy 32 1.1k 1.0× 680 0.6× 298 0.3× 354 0.6× 348 0.8× 74 2.4k
Hugh Rickards United Kingdom 40 1.4k 1.2× 1.3k 1.2× 1.4k 1.5× 1.4k 2.5× 1.2k 2.6× 124 4.1k
Sean S. O’Sullivan United Kingdom 35 3.7k 3.1× 579 0.5× 721 0.8× 1.2k 2.2× 756 1.7× 64 4.8k
Massimo Pasquini Italy 27 539 0.5× 441 0.4× 564 0.6× 240 0.4× 220 0.5× 103 2.3k

Countries citing papers authored by Glen Wunderlich

Since Specialization
Citations

This map shows the geographic impact of Glen Wunderlich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Glen Wunderlich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Glen Wunderlich more than expected).

Fields of papers citing papers by Glen Wunderlich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Glen Wunderlich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Glen Wunderlich. The network helps show where Glen Wunderlich may publish in the future.

Co-authorship network of co-authors of Glen Wunderlich

This figure shows the co-authorship network connecting the top 25 collaborators of Glen Wunderlich. A scholar is included among the top collaborators of Glen Wunderlich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Glen Wunderlich. Glen Wunderlich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wunderlich, Glen, et al.. (2023). Efficacy and Safety of Iclepertin (BI 425809) in Patients With Schizophrenia: CONNEX, A Phase III Randomized Controlled Trial Program. CNS Spectrums. 28(2). 229–229. 2 indexed citations
3.
Wunderlich, Glen, et al.. (2023). Efficacy and safety of the novel GlyT1 inhibitor BI 425809 in Alzheimer’s dementia: a randomized controlled trial. Alzheimer s Research & Therapy. 15(1). 24–24. 7 indexed citations
4.
Rosenbrock, Holger, Michael Desch, & Glen Wunderlich. (2023). Development of the novel GlyT1 inhibitor, iclepertin (BI 425809), for the treatment of cognitive impairment associated with schizophrenia. European Archives of Psychiatry and Clinical Neuroscience. 273(7). 1557–1566. 49 indexed citations
5.
Rentz, Dorene M., Alette M. Wessels, Ananth Annapragada, et al.. (2021). Building clinically relevant outcomes across the Alzheimer's disease spectrum. Alzheimer s & Dementia Translational Research & Clinical Interventions. 7(1). e12181–e12181. 28 indexed citations
6.
Desch, Michael, Glen Wunderlich, Karl‐Heinz Liesenfeld, et al.. (2021). Effects of Cytochrome P450 3A4 Induction and Inhibition on the Pharmacokinetics of BI 425809, a Novel Glycine Transporter 1 Inhibitor. European Journal of Drug Metabolism and Pharmacokinetics. 47(1). 91–103. 6 indexed citations
7.
8.
Tsuda, Yasuhiro, et al.. (2019). Pharmacokinetics of Single Doses of BI 425809 in Healthy Chinese and Japanese Subjects: A Randomized Study. Clinical Therapeutics. 41(5). 961–971. 10 indexed citations
9.
Moschetti, Viktoria, Maria Kim, Michael Sand, et al.. (2018). The safety, tolerability and pharmacokinetics of BI 409306, a novel and potent PDE9 inhibitor: Overview of three Phase I randomised trials in healthy volunteers. European Neuropsychopharmacology. 28(5). 643–655. 10 indexed citations
10.
Clayton, Anita H., David Goldmeier, Rossella E. Nappi, et al.. (2017). Sexual Interest and Desire Inventory—Female. 223–234.
11.
Moschetti, Viktoria, Michael Desch, Karl‐Heinz Liesenfeld, et al.. (2017). Safety, Tolerability and Pharmacokinetics of Oral BI 425809, a Glycine Transporter 1 Inhibitor, in Healthy Male Volunteers: A Partially Randomised, Single-Blind, Placebo-Controlled, First-in-Human Study. European Journal of Drug Metabolism and Pharmacokinetics. 43(2). 239–249. 28 indexed citations
12.
Kurlan, Roger, et al.. (2012). A multicenter randomized placebo‐controlled clinical trial of pramipexole for Tourette's syndrome. Movement Disorders. 27(6). 775–778. 41 indexed citations
13.
Voon, Valerie, Mandy Sohr, Anthony E. Lang, et al.. (2011). Impulse control disorders in parkinson disease: A multicenter case–control study. Annals of Neurology. 69(6). 986–996. 284 indexed citations
14.
Weintraub, Daniel, Mandy Sohr, Marc N. Potenza, et al.. (2010). Amantadine use associated with impulse control disorders in Parkinson disease in cross‐sectional study. Annals of Neurology. 68(6). 963–968. 114 indexed citations
15.
Weintraub, Daniel, Juergen Koester, Marc N. Potenza, et al.. (2010). Impulse Control Disorders in Parkinson Disease. Archives of Neurology. 67(5). 589–95. 971 indexed citations breakdown →
16.
Clayton, Anita H., Robert Segraves, Sandra R. Leiblum, et al.. (2006). Reliability and Validity of the Sexual Interest and Desire Inventory–Female (SIDI-F), a Scale Designed to Measure Severity of Female Hypoactive Sexual Desire Disorder. Journal of Sex & Marital Therapy. 32(2). 115–135. 110 indexed citations
17.
Wunderlich, Glen, et al.. (2004). Cholecystokinin modulation of locomotor behavior in rats is sensitized by chronic amphetamine and chronic restraint stress exposure. Brain Research. 1001(1-2). 95–107. 12 indexed citations
18.
Evans, Kenneth, Terrence Sills, Glen Wunderlich, & Heather McDonald. (2004). Worsening of depressive symptoms prior to randomization in clinical trials: a possible screen for placebo responders?. Journal of Psychiatric Research. 38(4). 437–444. 24 indexed citations
19.
Floresco, Stan, et al.. (1997). Disruption of spatial but not object-recognition memory by neurotoxic lesions of the dorsal hippocampus in rats.. Behavioral Neuroscience. 111(6). 1184–1196. 84 indexed citations
20.
Floresco, Stan, et al.. (1997). Disruption of spatial but not object-recognition memory by neurotoxic lesions of the dorsal hippocampus in rats.. Behavioral Neuroscience. 111(6). 1184–1196. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marı́a J. Portella Breakdown of academic impact, for papers by Raphael M. Bonelli Breakdown of academic impact, for papers by Seishi Terada Breakdown of academic impact, for papers by José Alvir Breakdown of academic impact, for papers by Tillmann H. C. Krüger Breakdown of academic impact, for papers by Ronald A. Remick Breakdown of academic impact, for papers by Claudio Lucetti Breakdown of academic impact, for papers by Hugh Rickards Breakdown of academic impact, for papers by Sean S. O’Sullivan Breakdown of academic impact, for papers by Massimo Pasquini
Rankless by CCL
2026